G. Larry Maxwell

Transcript expression in endometrial cancers from Black and White patients.

MicroRNAs in endometrial cancers from black and white patients.

Does aggressive surgery improve outcomes? Interaction between preoperative disease burden and complex surgery in patients with advanced-stage ovarian cancer: an analysis of GOG 182.

Reply to G.D. Aletti et al.

The state of advocacy in cancer.

Race-specific molecular alterations correlate with differential outcomes for black and white endometrioid endometrial cancer patients.

Impact of age at diagnosis on racial disparities in endometrial cancer patients.

Predictive modeling for determination of microscopic residual disease at primary cytoreduction: An NRG Oncology/Gynecologic Oncology Group 182 Study.

Racial disparities in molecular subtypes of endometrial cancer.

Biomarker panel for early detection of endometrial cancer in the Prostate, Lung, Colorectal, and Ovarian cancer screening trial.

Nitric Oxide Donor DETA/NO Inhibits the Growth of Endometrial Cancer Cells by Upregulating the Expression of RASSF1 and CDKN1A.

Impact of adjuvant treatment and prognostic factors in stage I uterine leiomyosarcoma patients treated in Commission on Cancer®-accredited facilities.

Survival disparities in vulvar cancer patients in Commission on Cancer®-accredited facilities.

Racial disparities in uterine and ovarian carcinosarcoma: A population-based analysis of treatment and survival.

Proteogenomic landscape of uterine leiomyomas from hereditary leiomyomatosis and renal cell cancer patients.

Extensive three-dimensional intratumor proteomic heterogeneity revealed by multiregion sampling in high-grade serous ovarian tumor specimens.

Peptide ancestry informative markers in uterine neoplasms from women of European, African, and Asian ancestry.

The ProMisE of uniform care for endometrial cancer patients.